- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Processa Pharmaceuticals Inc (PCSA)
Assess today's live Processa Pharmaceuticals Inc (PCSA) share price, performance and insights using our live NASDAQ: PCSA stock exchange data.
Analyse the historical data and Processa Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Processa Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Processa Pharmaceuticals (PCSA) stock price today with other investors in the Processa Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PCSA share price (ISIN: US74275C3043) to enhance your trading decisions with our free investment tools and resources.
What Is the Processa Pharmaceuticals Inc Share Price Today?
The Processa Pharmaceuticals share price today is 0.2146.
What Is the Stock Symbol for Processa Pharmaceuticals Inc
The stock symbol (or 'ticker') for Processa Pharmaceuticals Inc is "PCSA."
What Stock Exchange Does Processa Pharmaceuticals Inc Trade On?
Processa Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Processa Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Processa Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Processa Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Processa Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Processa Pharmaceuticals (PCSA) stock price today with other investors in the Processa Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PCSA share price (ISIN: US74275C3043) to enhance your trading decisions with our free investment tools and resources.
What Is the Processa Pharmaceuticals Inc Share Price Today?
The Processa Pharmaceuticals share price today is 0.2146.
What Is the Stock Symbol for Processa Pharmaceuticals Inc
The stock symbol (or 'ticker') for Processa Pharmaceuticals Inc is "PCSA."
What Stock Exchange Does Processa Pharmaceuticals Inc Trade On?
Processa Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Processa Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Processa Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
0.2146
+0.0024(+1.13%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.2101
0.2200
52 wk Range
0.1500
3.1000
PCSA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
PCSA is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.21010.2200
52 wk Range
0.15003.1000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PCSA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
2.0000
Upside
+831.97%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral
Processa Pharmaceuticals Company Profile
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. The company’s pipeline includes three chemotherapy drugs comprising Gemcitabine, PCS3117 that has completed Phase 2a clinical trials to treat pancreatic, biliary tract, lung, ovarian, breast, and other cancers; Capecitabine, a combination of PCS6422 and capecitabine, which is in Phase 2 clinical trials to treat metastatic colorectal, gastrointestinal, breast, pancreatic, and other cancers; and Irinotecan, PCS11T that is in pre-clinical studies to treat lung, colorectal, gastrointestinal, pancreatic, and other cancers. It also develops non-oncology drugs consisting of PCS12852 that is in Phase 2B clinical trials for treatment of gastroparesis; and PCS499 for the treatment of glomerular disease. The company has license agreements with Elion Oncology, Inc.; Ocuphire Pharma, Inc.; Aposense, Ltd.; Yuhan Corporation; and CoNCERT Pharmaceuticals, Inc. Processa Pharmaceuticals, Inc. was founded in 2017 and is based in Hanover, Maryland.
Compare PCSA to Peers and Sector
Metrics to compare | PCSA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPCSAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −1.5x | −0.5x | |
PEG Ratio | −0.01 | −0.01 | 0.00 | |
Price/Book | 1.6x | 0.5x | 2.6x | |
Price / LTM Sales | - | 2.5x | 3.2x | |
Upside (Analyst Target) | - | 89.5% | 43.8% | |
Fair Value Upside | Unlock | 10.9% | 5.1% | Unlock |
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2.0000
(+831.97% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-0.30 / -0.56
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Processa Pharmaceuticals (PCSA) Share Price Today?
The live Processa Pharmaceuticals share price today is 0.21
What Stock Exchange Does Processa Pharmaceuticals (PCSA) Trade On?
Processa Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Processa Pharmaceuticals?
The stock symbol (also called a 'ticker') for Processa Pharmaceuticals is "PCSA."
What Is the Current Processa Pharmaceuticals Market Cap?
As of today, Processa Pharmaceuticals market capitalisation is 5.60M.
What Is Processa Pharmaceuticals's (PCSA) Earnings Per Share (TTM)?
The Processa Pharmaceuticals EPS is currently -2.48 (Trailing Twelve Months).
Is PCSA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Processa Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Processa Pharmaceuticals Stock Split?
Processa Pharmaceuticals has split 3 times. (See the PCSA stock split history page for full effective split date and price information.)
How Many Employees Does Processa Pharmaceuticals Have?
Processa Pharmaceuticals currently has 10 employees.
What is the current trading status of Processa Pharmaceuticals (PCSA)?
As of 18 Jul 2025, Processa Pharmaceuticals (PCSA) is trading at a price of 0.21, with a previous close of 0.21. The stock has fluctuated within a day range of 0.21 to 0.22, while its 52-week range spans from 0.15 to 3.10.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.